Azer
PersonRelationship Network
HOUSE_OVERSIGHT_024840.jpg
This document is page 24 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the U.S. CBD market. It presents data suggesting the market size is approaching $2 billion based on consumer surveys and increasing Google search trends for CBD products like gummies, creams, and oils. The document bears a House Oversight Bates stamp (024840), indicating it was part of a document production to Congress, though no direct mention of Jeffrey Epstein appears on this specific page.
HOUSE_OVERSIGHT_024824.jpg
This document is page 8 of a Cowen market research report dated February 25, 2019, analyzing the market size and consumer demographics of CBD products. It details survey results from January 2019 showing a 6.9% usage rate, skewing towards younger demographics (18-34), and identifies tinctures as the dominant delivery mechanism. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (often associated with financial probes into banks connected to Jeffrey Epstein), the content of this specific page is strictly financial market analysis regarding CBD and tobacco/vaping products.
HOUSE_OVERSIGHT_024823.jpg
This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024822.jpg
This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024821.jpg
This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity